(4-氯磺酰基苯基)苯甲酸酯 | 89820-22-4

• 分子结构分类: 有机化合物 - 苯丙烷和聚酮 - 缩酚酸和缩酚酸环醚类
• 中文名称: (4-氯磺酰基苯基)苯甲酸酯
• 英文名称: 4-benzoyloxybenzenesulfonyl chloride
• 英文别名: 4-Benzoyloxy-benzolsulfonylchlorid；Benzenesulfonyl chloride, 4-(benzoyloxy)-；(4-chlorosulfonylphenyl) benzoate
• CAS: 89820-22-4
• 化学式: C₁₃H₉ClO₄S
• 分子量: 296.731
• InChiKey: JSFNLHHEZSHUMV-UHFFFAOYSA-N

物化性质

• 沸点：
  425.4±28.0 °C(Predicted)
• 密度：
  1.416±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  3.6
• 重原子数：
  19
• 可旋转键数：
  4
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.0
• 拓扑面积：
  68.8
• 氢给体数：
  0
• 氢受体数：
  4

反应信息

• 作为反应物：
  描述：

  (4-氯磺酰基苯基)苯甲酸酯 在 吡啶 作用下， 生成 4-hydroxy-benzenesulfonic acid-(4-methyl-pyrimidin-2-ylamide)
  参考文献：
  名称：

  Matsukawa et al., Yakugaku Zasshi/Journal of the Pharmaceutical Society of Japan, 1950, vol. 70, p. 557,560

  摘要：

  DOI：
• 作为产物：
  描述：

  alkaline earth salt of/the/ methylsulfuric acid 在 五氯化磷 作用下， 生成 (4-氯磺酰基苯基)苯甲酸酯
  参考文献：
  名称：

  Schreinemakers, Recueil des Travaux Chimiques des Pays-Bas, 1897, vol. 16, p. 420

  摘要：

  DOI：

文献信息

• SUBSTITUTED TETRAHYDROISOQUINOLINES USED IN THE FORM OF MMP INHIBITORS, METHOD FOR THE PRODUCTION AND USE THEREOF IN THE FORM OF DRUGS
  申请人：Hofmeister Armin

  公开号：US20070203118A1

  公开（公告）日：2007-08-30

  The present invention is directed to a compound of formula (I) wherein R 1 , R 2 , R 3 , R 4 , A, L and n are as defined herein, or a pharmacologically acceptable salt thereof, its pharmaceutical composition and it use as a MMP inhibitor.

  本发明涉及一种具有以下化学式(I)的化合物，其中R1、R2、R3、R4、A、L和n如本文所定义，或其药理学上可接受的盐，以及其药物组合物及其作为MMP抑制剂的用途。
• Sulfur substituted sulfonylaminocarboxylic acid N-arylamides, their preparation, their use and pharmaceutical preparations comprising them
  申请人：Aventis Pharma Deutschland GmbH

  公开号：US06335334B1

  公开（公告）日：2002-01-01

  The present invention relates to compounds of the formula I wherein A1, A2, R1, R2, R3, X and n are as defined in the claims, which are valuable pharmaceutically active compounds for the therapy and prophylaxis of diseases, for example of cardiovascular diseases such as hypertension, angina pectoris, cardiac insufficiency, thromboses or atherosclerosis. The compounds of the formula I are capable of modulating the body's production of cyclic guanosine monophosphate (cGMP) and are generally suitable for the therapy and prophylaxis of diseases which are associated with a disturbed cGMP balance. The invention furthermore relates to processes for preparing compounds of the formula I, to their use for the therapy and prophylaxis of the abovementioned diseases and for preparing pharmaceuticals for this purpose, and to pharmaceutical preparations which comprise compounds of the formula I.

  本发明涉及以下式I的化合物，其中A1、A2、R1、R2、R3、X和n如权利要求中所定义，这些化合物是有价值的药用活性化合物，可用于治疗和预防疾病，例如心血管疾病，如高血压、心绞痛、心力衰竭、血栓形成或动脉粥样硬化。式I的化合物能够调节体内环鸟苷酸单磷酸（cGMP）的产生，并且通常适用于治疗和预防与破坏cGMP平衡有关的疾病。此外，本发明还涉及制备式I化合物的方法，它们用于治疗和预防上述疾病以及用于制备用途的药物，以及包含式I化合物的药物制剂。
• Phytotoxic Activity of<i>N</i>-Benzylbenzenesulfonamides
  作者：Koichi Yoneyama、Nobumasa Ichizen、Hiroyoshi Omokawa、Yasutomo Takeuchi、Makoto Konnai、Tetsuo Takematsu

  DOI：10.1080/00021369.1984.10866170

  日期：1984.2

  A series of N-benzylbenzenesulfonamides were synthesized and their biological activities were tested. Among these compounds, N-(2,3-epoxypropyl)-N-(α-methylbenzyl)benzenesulfonamide derivatives were found to be the most active against barnyardgrass and to have physiological selectivity between barnyardgrass and rice plants.

  我们合成了一系列 N-苄基苯磺酰胺类化合物，并测试了它们的生物活性。在这些化合物中，N-(2,3-环氧丙基)-N-(α-甲基苄基)苯磺酰胺衍生物对稗草的活性最强，并且在稗草和水稻植物之间具有生理选择性。
• N-(2,3-Epoxypropylene)-n-aralkylsulfonamide and herbicidal compositions
  申请人：Mitsubishi Chemical Industries Ltd.

  公开号：US04468245A1

  公开（公告）日：1984-08-28

  An N-(2,3-epoxypropylene)-N-aralkylsulfonamide of formula (I): ##STR1## wherein R.sup.1 is an alkyl group, a haloalkyl group, an aralkyl group or an aryl group which may be substituted, R.sup.2 and R.sup.3, independently of each other, are a hydrogen atom or an alkyl group, R.sup.4 and R.sup.4', independently of each other, are a hydrogen atom, an alkyl group, an alkoxy group or a halogen atom, R.sup.5, R.sup.6 and R.sup.7, independently of each other, are a hydrogen atom, an alkyl group, a haloalkyl group or an aryl group, and n is 0 or 1. The novel compounds have excellent herbicidal effect based on the physiological selectivity between rice plant and weeds, and have low phytotoxicity against rice plant.

  公式（I）中的N-（2,3-环氧丙烷基）-N-烷基磺酰胺：##STR1##其中R.sup.1是烷基，卤代烷基，芳基烷基或取代的芳基；R.sup.2和R.sup.3独立地是氢原子或烷基；R.sup.4和R.sup.4'独立地是氢原子，烷基，烷氧基或卤素原子；R.sup.5，R.sup.6和R.sup.7独立地是氢原子，烷基，卤代烷基或芳基；n为0或1。这些新化合物基于水稻植物和杂草之间的生理选择性具有出色的除草效果，并且对水稻植物的植物毒性较低。
• Substituted benzimidazole compounds and their use for the treatment of cancer
  申请人：Clerc Francois

  公开号：US20050014811A1

  公开（公告）日：2005-01-20

  The present invention discloses and claims benzimidazole compounds of formula (I): in which A is aryl or heteroaryl; R 1 is sleceted from optionally substituted alkyl, alkoxy, aryl or heteroaryl, NH-lower alkyl or NH-cycloalkyl, or halogen, NH 2 ; 1-imidazolyl or SO 2 Me; R 2 is selected from optionally substituted —CO-alkyl, —CO-cycloalkyl, —CO-aralkyl, —CO-aryl, —CO-alkoxy, aryl or aralkyl, or —O-amino, CO—NHR 3 or CO—R 3 R 4 wherein R 3 and R 4 are selecteded independently from hydrogen, alkyl, hydroxyalkyl, alkoxyalkyl, fluoroalkyl, alkynyl, heteroalkyl, alkylheteroalkyl, aryl, aralkyl or together form an alkylene chain optionally containing one to 4 heteroatoms; a pharmaceutically acceptable salt or a prodrug thereof; the use of compounds of formula (I) for the treatment of cancer, and pharmaceutical compositions comprising a compound of formula (I) and one or more pharmaceutically acceptable adjuvants or diluents.

  本发明揭示和声明了公式(I)的苯并咪唑化合物： 其中A是芳基或杂芳基；R1选自可选取代的烷基，烷氧基，芳基或杂芳基，NH-较低烷基或NH-环烷基，或卤素，NH2；1-咪唑基或SO2Me；R2选自可选取代的-CO-烷基，-CO-环烷基，-CO-芳基烷基，-CO-芳基，-CO-烷氧基，芳基或芳基烷基，或-O-氨基，CO-NHR3或CO-R3R4，其中R3和R4独立选择自氢，烷基，羟基烷基，烷氧基烷基，氟烷基，炔基，杂基，烷基杂基，芳基，芳基烷基或在其中形成一个含有1到4个杂原子的烷基链;其药学上可接受的盐或前药；使用公式(I)的化合物治疗癌症，以及包含公式(I)的化合物和一个或多个药学上可接受的辅料或稀释剂的制药组合物。